We have identified a novel c-Jun N-terminal kinase (JNK)-interacting protein, Sab, by yeast two-hybrid screening. Sab binds to and serves as a substrate for JNK in itro, and was previously found to interact with the Src homology 3 (SH3) domain of Bruton's tyrosine kinase (Btk). Inspection of the sequence of Sab reveals the presence of two putative mitogenactivated protein kinase interaction motifs (KIMs) similar to that found in the JNK docking domain of the c-Jun transcription factor, and four potential serine-proline JNK phosphorylation sites in the C-terminal half of the molecule. Using deletion and site-directed mutagenesis, we demonstrate that the most
INTRODUCTION
Vertebrate cells contain multiple mitogen-activated protein (MAP) kinase pathways, of which the three best characterized terminate in the extracellular-signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK) and p38 MAP kinases. Individual MAP kinase subfamilies are activated by distinct stimuli ; the ERK pathway is stimulated primarily by growth factors and trophic signals, whereas the JNK and p38 pathways are activated most potently by inflammatory cytokines and a variety of chemical and radiant stresses [1] . MAP kinase pathways are thought to play a role in the regulation of a wide variety of cellular processes. The JNK pathway, for example, has been implicated in cell proliferation, differentiation, apoptosis, immune cell function and embryonic morphogenesis [2] . In view of the pleiotropic endpoints of JNK signalling, it seems likely that JNK must act on many cellular substrate proteins ; however, only a relatively small number of JNK targets have been identified so far [2] .
The most thoroughly characterized JNK substrate is c-Jun, a transcription factor whose activity is selectively stimulated through JNK-mediated phosphorylation of two regulatory serine residues (Ser-63\Ser-73) contained within the N-terminal transcriptional activation domain [3, 4] . Efficient modification of Ser63\Ser-73 in c-Jun depends on binding of JNK to c-Jun via a docking motif located immediately N-terminal to the phosphoacceptor sites themselves (the delta region) [5] . JNK also phosphorylates a number of other transcription factors, including ATF-2 (activating transcription factor-2), Elk-1 and NFAT Abbreviations used : Btk, Bruton's tyrosine kinase ; CEF, chick embryo fibroblasts ; CoxIV, cytochrome c oxidase complex IV ; DMEM, Dulbecco's modified Eagle's medium ; ERK, extracellular-signal-regulated kinase ; GST, glutathione S-transferase ; HFF, human foreskin fibroblasts ; JIP1 (etc.), JNK-interacting protein 1 (etc.) ; JNK, c-Jun N-terminal kinase ; KIM, kinase interaction motif ; MAP kinase, mitogen-activated protein kinase ; PDI, protein disulphide isomerase ; SH3, Src homology 3 ; SP residue, serine-proline residue. 1 To whom correspondence should be addressed (e-mail d.gillespie!beatson.gla.ac.uk).
N-terminal KIM in Sab is essential for JNK binding, and that, as with c-Jun, physical interaction with JNK is necessary for Sab phosphorylation. Interestingly, confocal immunocytochemistry and cell fractionation studies indicate that Sab is associated with mitochondria, where it co-localizes with a fraction of active JNK. These and previously reported properties of Sab suggest a possible role in targeting JNK to this subcellular compartment and\or mediating cross-talk between the Btk and JNK signal transduction pathways.
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(nuclear factor of activated T-cells), each of which also contains docking motifs which enable binding of JNK [6] . Protein-protein interactions therefore play a major role in JNK substrate selection. JNK also participates in docking interactions with a variety of scaffold proteins, upstream activators and MAP kinase phosphatases [2, 6] . In most cases the functional consequences of these interactions are not yet fully understood ; however, they are likely to play an important role in regulating JNK signal transduction. In particular, the JNK-interacting protein 1 (JIP1), JIP2 and JIP3 [7, 8] scaffold proteins organize complexes containing multiple JNK pathway components, including JNK itself, immediate upstream activators such as MKK (MAP kinase kinase) 4\7, and more distal upstream elements such as MLK (mixed-lineage kinase) and MEKK (MAP kinase\ERK kinase kinase) family kinases [2] . Such scaffold complexes are thought to enhance the efficiency and specificity of JNK signalling by minimizing cross-talk with other pathways, and may also play a role in targeting JNK to a specific subcellular localization and\or restricted subset of substrates [2] .
Understanding how JNK activation evokes specific and distinct biological responses in different cellular contexts represents a major challenge. Changes in gene transcription induced via c-Jun or other transcriptional effectors represent an important endpoint of JNK signalling ; however, it is clear that JNK can also act via non-transcriptional mechanisms. For example, studies using cells from compound mutant mice that lack functional JNK1 and JNK2 genes have established that JNK is required for apoptosis in mouse embryo fibroblasts exposed to UV irradiation and other stresses [9] . Importantly, in this system JNK triggers cell death by promoting the release of cytochrome c from mitochondria via a mechanism that is independent of new gene transcription [9] .
Understanding non-transcriptional JNK signalling processes will require a comprehensive identification of non-nuclear JNK substrates and detailed characterization of the mechanisms that target JNK to specific subcellular compartments. In view of the important role that protein-protein interactions play in targeting JNK to known substrates and regulators, we sought to identify novel JNK-interacting proteins by yeast two-hybrid screening. This approach led to the isolation of a protein, Sab (SH3BP5), which we have shown can bind to and serve as a substrate for JNK in itro. Although the biological function of Sab is not yet known, we have found that Sab associates with mitochondria, where it co-localizes with a fraction of active JNK. Interestingly, Sab was previously isolated in a screen for proteins capable of binding to the Src homology 3 (SH3) domain of Bruton's tyrosine kinase (Btk) [10] . Btk is essential for B-cell development [11, 12] and has been implicated in both JNK signalling and apoptosis in B cells and mast cells [13] . These observations suggest that Sab could play a role in targeting JNK and Btk to mitochondria and\or mediating cross-talk between the JNK and Btk signalling pathways.
EXPERIMENTAL Yeast two-hybrid screen
To identify novel JNK-interacting proteins, a two-hybrid screen was carried out using the DupLEX-A (Origene) system. A human HeLa cell cDNA library was screened using the rat homologue of JNK3 [14] (also known as SAPK-β ; [15] ). Of 1.5i10' independent clones screened, 11 were found to show a reproducible interaction with JNK3. The cDNAs contained within these clones were purified and sequenced.
Cell lines and preparation of cell extracts
Normal and Myc-transformed chick embryo fibroblasts (CEF) were grown in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10 % (v\v) newborn calf serum at 41 mC in a humidified 5 % CO # incubator, as reported previously [16, 17] . Human squamous epithelial carcinoma (A431) cells were grown in DMEM supplemented with 10 % (v\v) foetal calf serum at 37 mC in 5% CO # . Human foreskin fibroblasts (HFF) were grown in DMEM supplemented with 20 % (v\v) foetal calf serum under humid conditions at 37 mC in 5% CO # . Murine mammary epithelial (KIM-2) cells were grown at 37 mC in 5% CO # in a 1 : 1 (v\v) mixture of DMEM and nutrient mixture F12 supplemented with 10 % (v\v) foetal calf serum.
For pull-down experiments, cell extracts were prepared from Myc-transformed CEF (150 mm dishes) after treatment with 10 µg\ml anisomycin (Sigma) for 15 min to activate JNK. Myctransformed CEF were used as a source of active JNK for convenience, owing to their rapid proliferation and high saturation density in culture. After three washes in cold PBS, cells were scraped into 1 ml of Lysis Buffer J, swelled on ice, and extracts were collected after centrifugation, as described previously [18] . Extracts were also prepared for Western blot analysis from normal CEF, A431 cells, HFF and KIM-2 cells without any pretreatment, as above.
Cytosolic and membrane extracts were prepared by centrifugal separation essentially as described in [19] . Briefly, cells were rinsed in PBS prior to resuspension in 5 vol. of Buffer A (20 mM Hepes, pH 7.5, 10 mM KCl, 1.5 mM MgCl # , 1 mM EDTA, 1 mM EGTA, 1 mM dithiothreitol and 0.1 mM PMSF) and lysed gently by incubation in a sonicating water-bath for 5 min, which was followed by two rounds of centrifugation at 750 g for 10 min to remove nuclei. Supernatants were further centrifuged at 10 000 g for 15 min to generate a pellet fraction enriched in mitochondria. This supernatant was then centrifuged at 100 000 g for 1 h to generate a pellet fraction enriched in endoplasmic and plasma membranes and a residual S-100 cytosol fraction.
DNA manipulations
All routine DNA manipulations were carried out according to standard procedures [20] . Glutathione S-transferase (GST)-Sab-(219-425) fusion protein was generated by cloning the partial cDNA encoding Sab-(219-425) isolated from the yeast twohybrid screen into pGEX-4T-1 (Amersham Pharmacia Bioscience). C-terminal deletion mutants of Sab-(219-425) were generated by PCR, cloned into the pPCR-Script vector (Stratagene) and their authenticity verified by sequencing. The PCR products for the truncated forms were then cloned into pGEX-4T-1 to generate GST-Sab-(219-390), GST-Sab-(219-353) and GST-Sab-(219-309). Kinase interaction motif (KIM) mutants were generated using the Quik-Change Site Directed Mutagenesis system (Stratagene), according to the manufacturer's instructions. The sequences of the primers used in PCR and site-directed mutagenesis are available on request.
GST pull-down and kinase assays
GST, GST-c-Jun-(1-79) (a gift from I. Morgan, Department of Veterinary Pathology, University of Glasgow, U.K.) and the GST-Sab proteins were expressed and purified from Escherichia coli as described previously [21] . For JNK pull-down assays, glutathione-Sepharose beads loaded with 5 µg of GST, GSTc-Jun-(1-79) or GST-Sab protein were incubated with 2 mg of cell extract as described [18] . After extensive washing, bound proteins were eluted and resolved by SDS\PAGE, and active JNK was detected by Western blotting using a polyclonal antibody specific for the dual phosphorylated form of JNK (New England Biolabs).
To capture active JNK for kinase assays, 30 µg of GST or GST-c-Jun-(1-79) fusion protein bound to glutathioneSepharose beads was incubated with 10 mg of anisomycinactivated Myc-transformed CEF cell extract. After extensive washing, each set of beads was divided equally between five 1.5 ml tubes, 3 µg of the different GST-Sab fusion proteins was added and in itro kinase assays were performed in the presence of 20 µM ATP and 0.11 MBq of [γ-$#P]ATP [5] . Reactions were resolved by SDS\PAGE and immobilized on nitrocellulose, after which autoradiography was carried out and active JNK was visualized by Western blotting using a polyclonal antibody specific for the phosphorylated form of JNK (New England Biolabs). Where required, the level of phosphorylation of Sab by JNK was quantified by laser densitometry of the autoradiograph, using a 420oe scanner with Quantity One2 software (pdi).
Generation of anti-Sab-(219-425) antibodies and Western blotting
GST-Sab-(219-425) was digested with thrombin, and the purified Sab-(219-425) portion was used as an immunogen to generate a polyclonal antiserum in New Zealand white rabbits. The antiserum was then used for Western blotting, immunoprecipitation and immunocytochemistry. For Western blotting of whole-cell extracts, 50 µg of cell extract was resolved by SDS\PAGE, immobilized on nitrocellulose, and probed with anti-Sab-(219-425) antiserum diluted 1 : 5000 in TBST (20 mM Tris\HCl, pH 7.6, 275 mM NaCl and 0.1 % Tween 20) containing 5 % (w\v) non-fat dry milk.
In vitro transcription/translation and immunoprecipitation
Coupled in itro transcription\translations of pPCR-Script-Sab-(1-425) and the series of pcDNA3 vectors containing cDNAs encoding all ten isoforms of JNK (a gift from R. J. Davis ; [14] ) were carried out from the T7 promoter using the TnT2 Coupled Reticulocyte Lysate System (Promega). GST pull-downs were carried out on a portion of the JNK translation reactions using 5 µg of GST, GST-c-Jun-(1-79) and GST-Sab-(219-425) beads, according to a previously reported method [14] . After washing, bound proteins were eluted and resolved by SDS\PAGE, and the gel was fixed, treated with Amplify (Amersham Pharmacia), dried and exposed to Fuji Super RS film. In itro translated Sab-(1-425) was divided between three 1.5 ml tubes and immunoprecipitated with preimmune serum, anti-Sab-(219-425) and antiSab-(1-99) as described previously [22] . Immunoprecipitates were resolved by SDS\PAGE, and the gel was processed and analysed by autoradiography as described above.
Immunocytochemistry
CEF, A431 cells, HFF and KIM-2 cells were grown under the conditions described above on glass coverslips, then fixed and permeabilized as described in [23] . The subcellular localization of mitochondria and endoplasmic reticulum was established using antibodies specific for cytochrome c oxidase complex IV (CoxIV ; Molecular Probes) and protein disulphide isomerase (PDI ; Stressgen) respectively. The localization of Sab and active JNK was visualized using anti-Sab-(219-425) and a phospho-JNK monoclonal antibody (Cell Signalling Technologies) respectively. In each case, Sab was visualized using a Texas Red-conjugated anti-rabbit secondary antibody, while the localization of CoxIV, PDI and phospho-JNK was observed using an FITC-conjugated anti-mouse antibody. Mitochondrial localization was confirmed by staining with Mito Tracker CMXRos (Molecular Probes) according to the manufacturer's instructions. Where required, JNK was activated in CEF by treatment with 10 µg\ml anisomycin for 15 min.
RESULTS

Sab binds to and serves as a substrate for JNK
To identify novel JNK-interacting proteins, a yeast two-hybrid screen was performed using JNK3 as a bait. Of 11 potential JNK-interacting clones isolated, one was found to contain a partial cDNA encoding part of a previously identified SH3-domain-binding protein, Sab [10] . In this clone, in-frame fusion between the lexA DNA-binding domain and Sab occurred at nucleotide 718 of the Sab cDNA sequence (GenBank accession number AB005047), resulting in a hybrid LexA protein encoding amino acids 219-425 of Sab ( Figure 1A) .
To confirm that the Sab C-terminus binds to JNK, a peptide comprising amino acids 219-425 of Sab was expressed as a GST fusion protein and tested for JNK binding in a pull-down assay. Extracts prepared from cells treated with anisomycin to activate JNK were incubated with GST-Sab-(219-425), GST-c-Jun-(1-79) or GST alone, and after extensive washing bound proteins were eluted and analysed by Western blotting using an antibody specific for the phosphorylated, active form of JNK. As shown in Figure 1(B) , the results of this experiment confirmed that GST-Sab-(219-425), like GST-c-Jun-(1-79), was able to capture GST pull-down assays were performed using GST, GST-c-Jun-(1-79) and the panel of GST-Sab proteins indicated in (A). Extracts were prepared from cells treated with anisomycin (10 µg/ml) to activate JNK and incubated with the indicated GST fusion proteins. After extensive washing, bound proteins were eluted and analysed by SDS/PAGE followed by Western blotting using an anti-phospho-JNK polyclonal antibody.
active JNK from cell extracts. The 54 kDa isoforms of JNK were less evident when GST-Sab-(219-353) was used as the affinity matrix compared with GST-c-Jun-(1-79), GST-Sab-(219-425) and GST-Sab-(219-390) ; however, this appears to be due to comigration with the very abundant GST-Sab-(219-353) fusion protein, which interferes with detection of these highermolecular-mass species by Western blotting, rather than representing a true difference in the spectrum of JNK isoforms captured by each matrix (see also Figure 2 ). Preliminary studies indicate that Sab appears to preferentially capture active -as opposed to inactive -JNK (results not shown).
Sab was first isolated by virtue of its ability to bind to the SH3 domain of Btk [10] , and the minimal region of Sab required for this interaction was shown to reside between amino acids 163-193 (dark grey box in Figure 1A ). Computer analysis of the Sab protein sequence indicates that the N-terminal half of the protein (light grey box in Figure 1A ) exhibits similarity to the rod domain of myosin heavy chain, and is predicted to have a high probability of forming an extended coiled coil, while the C-terminal half of Sab, which binds to JNK, exhibits no extended similarity to any other protein in the public databases (G. H. W. May and C. Wiltshire, unpublished work). Within this latter segment, however, are two short sequences that are similar to the KIM [consensus K\R(X) $ -& LXL, where X stands for any amino acid] which is found in the c-Jun δ domain and other transcription factors that can bind JNK or other MAP kinases [6] . In Sab these
Figure 2 Sab can serve as a substrate for JNK
Active JNK was captured from anisomycin-treated cell extracts using a GST-c-Jun-(1-79) matrix. After extensive washing, the ability of bead-bound JNK to phosphorylate the panel of GST-Sab fusion proteins ( Figure 1A ) was tested in in vitro kinase assays in the presence of [γ-
32 P]ATP. Kinase reactions were resolved by SDS/PAGE analysis and transferred to nitrocellulose membranes. Phosphorylated proteins were detected by autoradiography (upper panel), while the presence of equal amounts of active JNK in each reaction was confirmed by probing with a phospho-specific JNK antibody (lower panel). Figure 1A ) are located between amino acids 313-319 (RPGSLDL) and 400-406 (RMKQLSL). The C-terminal half of Sab also contains four serine-proline (SP) residues, i.e. Ser$!!, Ser$#", Ser$%' and Ser$*" ( Figure 1A ), which could potentially serve as JNK phosphorylation sites.
KIM-like sequences (black boxes in
To determine whether the putative KIMs in Sab are required for JNK binding, we first prepared C-terminal deletion derivatives of GST-Sab-(219-425) that lacked either one or both sequences ( Figure 1A ). As shown in Figure 1(B) , GST-Sab-(219-390) and GST-Sab-(219-353), which both retain the most N-terminal KIM-like motif, still bind JNK, while GST-Sab-(219-309), which lacks both, does not. These results suggest that at least one putative KIM sequence is required for JNK binding to Sab.
We also investigated whether Sab can serve as a substrate for JNK. To this end, active JNK was captured on a GST-c-Jun-(1-79) matrix [18] and tested for its ability to phosphorylate GST-Sab-(219-425) in the presence of [γ-$#P]ATP in itro. Mock reactions using a GST matrix were used to control for non-specific kinase activity. As shown in Figure 2 , GSTSab-(219-425) became labelled when incubated with the GST-cJun-(1-79) matrix bearing active JNK (Figure 2, lower panel) , but not in the presence of the control matrix, indicating that Sab can be phosphorylated by JNK. Strikingly, although GST-Sab-(219-390) and GST-Sab-(219-353) were also phosphorylated by JNK, GST-Sab-(219-309) was not. The failure of this shortest Sab construct to serve as substrate for JNK could reflect either loss of the site(s) that in longer derivatives is modified by JNK, or, alternatively, that binding of JNK is required for phosphorylation, as in c-Jun [5] .
To investigate further the role of the putative Sab KIM elements and the relationship between JNK binding and phosphorylation, site-directed mutagenesis was used to replace both leucines in the conserved LXL motifs with alanine residues ( Figure 3A) . Analogous mutations in the c-Jun JNK docking region KIM have been shown to disrupt both JNK binding and phosphorylation [24] . Mutant derivatives of GST-Sab-(219-425) lacking one (-K1, -K2) or both (-K1-K2) KIMs were generated and tested for their ability to bind to and serve as substrates for JNK. As shown in Figure 3 (B) (upper panel), this analysis revealed that K1 was absolutely required for phospho-JNK binding, whereas K2 was dispensable. Mutants lacking K1 also failed to serve as substrates for JNK when incubated with active JNK bound to a GST-c-Jun-(1-79) matrix ( Figure 3B , lower panel). Since these mutants retain all of the potential JNK phosphorylation sites, this demonstrates that binding of JNK is required for efficient phosphorylation of Sab.
Sab interacts with protein kinases encoded by JNK1, JNK2 and JNK3
Sab was isolated in a yeast two-hybrid screen using JNK3 as a bait. Since JNK3 has a relatively restricted tissue-specific distribution [25] , and antibodies specific for active JNK do not distinguish between products encoded by the different JNK family members, it was of interest to determine whether Sab can also interact with the products of the ubiquitously expressed JNK1 and JNK2 genes. To this end, all ten JNK isoforms encoded by the JNK1, JNK2 and JNK3 genes [14] were synthesized by in itro transcription\translation and tested for binding to GST-Sab-(219-425) using GST-c-Jun-(1-79) for comparison. Although there was considerable variation in efficiency, GST-Sab-(219-425) was able to bind all JNK isoforms (Figure 4) .
Sab is associated with mitochondria
To facilitate immunolocalization and further biochemical studies, a polyclonal rabbit antiserum was raised using the Sab-(219-425) portion of the GST-Sab-(219-425) fusion protein as an immunogen (see the Experimental section for details). The resulting antiserum was tested for its ability to precipitate in itro generated full-length Sab protein using a previously described N-terminal Sab antibody [anti-Sab-(1-99)] for comparison [10] . As shown in Figure 5(A) (left panel) , both anti-Sab-(219-425) and anti-Sab-(1-99) precipitated full-length Sab protein translated in itro. When tested in Western blotting, the anti-Sab-(219-425) antibody recognized a protein of approx. 70 kDa in size in human (A431, HFF), murine (KIM-2) and avian (CEF) cells, which is close to the previously observed size for full-length Sab protein ( Figure 5A , right panel ; [10] ). A larger species was also recognized in some cell extracts (indicated by an asterisk in Figure 5A ), which may correspond to splice variants of Sab [10] or Sab proteins that have undergone post-translational modification(s). No information as to the subcellular localization of Sab has been reported ; therefore immunolocalization studies were carried out on the panel of cells analysed by Western blotting. A distinctive pattern of staining was observed in all cell types which indicated that Sab was associated with punctate or strand-like structures that were excluded from the nucleus ( Figure 5B ). This staining pattern was highly reproducible, and was not observed in cells stained with the preimmune serum or second antibody alone (results not shown).
In order to identify these subcellular structures, co-localization experiments were carried out using antibodies to a number of organelle markers ( Figure 6 ). Antibodies against CoxIV and PDI gave specific and distinct patterns of localization, identifying the mitochondria and endoplasmic reticulum respectively ( Figures  6C and 6D) . While there was no discernable co-localization of Sab and PDI ( Figure 6F ), almost complete co-localization was observed between Sab and CoxIV ( Figure 6E ). That these structures did in fact correspond to mitochondria was confirmed by staining with MitoTracker CMXRos, a dye that accumulates in active mitochondria (results not shown). These results indicate that Sab is associated with mitochondria, a conclusion supported by cell fractionation studies described below.
Sab co-localizes with a subset of active JNK in mitochondria
Since Sab has the potential to bind to active (phospho-)JNK, it was of interest to determine if these molecules associate with the same subcellular structures in i o. In untreated CEF, an antiphospho-JNK monoclonal antibody exhibited weak cytoplasmic staining, which was punctate and partially coincident with that of Sab ( Figures 7A, 7C and 7E ). However, unlike Sab, phospho-JNK did not appear to be excluded from the nucleus ( Figure 7C ). When cells were treated with anisomycin to activate JNK, both nuclear and cytoplasmic phospho-JNK staining increased markedly, and in the cytoplasm it was evident that a portion of the active JNK was associated with the same punctate or thread-like structures as Sab ( Figures 7B, 7D and 7F ). In contrast, no colocalization of Sab with active p38 or ERK MAP kinases was observed (results not shown).
To confirm these observations using an alternative approach, we investigated the distribution of Sab and active JNK by subcellular fractionation. Control and anisomycin-treated CEF were lysed and sequential centrifugation was used to isolate fractions enriched in mitochondria (HM), endoplasmic reticulum plus plasma membranes (LM) and cytosol (Cyto) (Figure 8 ). The distributions of Sab, active JNK, the mitochondrial marker protein CoxIV and the endoplasmic reticulum marker PDI in these fractions were then determined by Western blotting. This analysis (Figure 8 ) revealed that Sab was concentrated in the mitochondrial (HM) fraction both before and after stimulation, but that approx. 50 % of non-nuclear active JNK was also present in this fraction after anisomycin treatment. No active JNK or Sab was present in the fraction enriched in endoplasmic reticulum (LM). Thus Sab and a fraction of active phospho-JNK co-localize to mitochondria after JNK activation, as judged by both confocal microscopy and biochemical analysis.
DISCUSSION
In the present study we describe the isolation of a new JNKinteracting protein, Sab, which was shown previously to bind selectively to the SH3 domain of Btk [10] . The native Sab protein is 425 amino acids long [10] , although our yeast two-hybrid
Figure 8 Co-localization of Sab and a portion of phospho-JNK with mitochondria during subcellular fractionation
Growing CEF (left) or CEF that had been treated with anisomycin to activate JNK (right) were fractionated by sequential centrifugation to generate fractions enriched in mitochondria (HM), endoplasmic reticulum plus plasma membranes (LM) and cytosol (Cyto). Equal amounts of protein from each fraction were then resolved by SDS/PAGE and transferred to nitrocellulose, and the presence of Sab, active phospho-JNK, CoxIV and PDI proteins was determined by Western blotting.
screen using JNK3 as a bait retrieved a partial Sab cDNA encoding residues 219-425. This C-terminal segment of Sab exhibits no extended similarity to any other known or predicted protein ; however, it contains two short sequences which match the consensus JNK docking (KIM) motif found in c-Jun, and four SP residues that could serve as potential JNK phospho-acceptor sites. As one might predict from these features, Sab can bind to and serve as a substrate for JNK in itro, and has the potential to bind all known JNK isoforms encoded by the JNK1, JNK2 and JNK3 genes [14] .
Interestingly, deletion and point mutants of Sab that lack the most N-terminal of these KIM-like sequences (RPGSLDL) no longer bind to JNK, indicating that this represents a bona fide JNK docking motif analogous to that found in c-Jun. In addition, such mutants no longer serve as substrates for JNK, even when they retain all of the four potential SP JNK phosphorylation sites. Thus, as with c-Jun [5] , binding of JNK is required for efficient phosphorylation of Sab in itro, although further work will be required to establish whether or not Sab, like c-Jun, serves as a substrate for JNK in i o. Interaction of JNK with Sab could not be detected by co-immunoprecipitation (results not shown). However, this method has also proved unsuccessful for detecting the interaction of JNK with the paradigm (and known physiological) substrate, c-Jun [5] , presumably because c-Jun-JNK and Sab-JNK complexes are insufficiently stable to survive the coimmunoprecipitation process, or alternatively, form only transiently in i o. Further work will be required to distinguish between these possibilities ; however, it is evident from these results that the JNK binding properties of Sab are comparable with those of c-Jun.
The amino acid sequence of full-length Sab provides few other clues as to its possible function(s). The N-terminal half of the protein exhibits similarity to the rod domain of myosin heavy chain and is predicted to have a high probability of forming an extended coiled coil. Although the significance of this putative coiled-coil region is unknown, full-length Sab can also bind and serve as a substrate for JNK (C. Wiltshire, unpublished work). The minimal region of Sab required for binding to the SH3 domain of Btk is located in the centre of the molecule between amino acids 163-193 [10] . This region lies outside the minimal region required for JNK binding ( Figure 1A) ; however, whether Sab can bind JNK and Btk simultaneously remains to be determined.
The finding that Sab co-localizes with active JNK at mitochondria was unexpected. Association of JNK with mitochondria has been reported previously [26, 27] , and phosphorylation of Bcl-2 or Bcl-xL proteins has been proposed as a possible mechanism through which JNK signalling could modulate apoptosis via cytochrome c release [26, 28] . One possibility, therefore, is that Sab might act as an anchor molecule that recruits JNK to mitochondria in order to facilitate phosphorylation of Bcl-2 or other targets. Alternatively, phosphorylation of Sab itself by JNK could affect mitochondrial function in some way. Clearly, it will be important to test these ideas, although such experiments will be complicated by the fact that JNK-mediated phosphorylation has been reported to both inhibit and promote the antiapoptotic function of Bcl-2 [26, 28, 29] , while JNK activation does not always correlate with Bcl-2 phosphorylation in i o, for unknown reasons [30] .
Finally, it is striking that Sab has also been shown to interact with the SH3 domain of the tyrosine kinase Btk [10] . As with JNK, Btk has been implicated in both pro-and anti-apoptotic signalling processes [31] [32] [33] , although the underlying mechanisms are incompletely understood. Experimental overexpression of Sab inhibits Btk activity [34] , suggesting that the Sab-Btk interaction is likely to be physiologically significant. It is well established that Btk can activate the JNK pathway [13] , and in certain cases JNK has been implicated as an intermediate in apoptosis triggered by Btk [31] . One possibility, therefore, is that Sab acts as a scaffold that facilitates or co-ordinates cross-talk between the Btk and JNK pathways. Alternatively, Sab might recruit Btk to a specific subcellular location, such as mitochondria, although, unlike with JNK, we are not aware of direct evidence for association of Btk with this organelle. Further work will be required to understand the functional significance of interactions between Sab, JNK and Btk.
